Medical & Scientific Advisory Board


Lon McCroskey,  MD, FACS
is a board-certified surgeon with Midwest Breast Care at Menorah Medical Center in Overland Park, Kan. With more than 30 years of surgical experience.
Bret Miller was Dr. Lon McCroskey’s 13th
Male Breast Cancer patient and the Doctor that asked Bret to put a Face to Male Breast Cancer on May 17th , 2010 the day before Bret’s Mastectomy!
Look where we are today because of his request!
See Dr. McCroskey’s website for complete BIO

Robert L. Bard, MD, PC, DABR, FASLMS
is internationally known and recognized as a leader in the field of 21st Century 3-D ULTRASONOGRAPHIC VOLUMETRIC DOPPLER IMAGING. Dr. Bard specializes in advanced 3-D sonography to detect cancers in numerous organs including the breast, prostate, skin, thyroid, melanoma and other areas. Dr. Bard’s images are used to accurately guide biopsies, target therapy and provide focused follow-up after treatment.
See Dr. Bard’s website for complete BIO

Oliver Bogler PhD.
Sharing knowledge is a powerful way to change the world and reduce inequities. In 2018 I joined the ECHO Institute at the University of New Mexico and am the current CEO of Project ECHO democratizing expert knowledge to change societal outcomes with an emphasis on the underserved, and strong engagements in health care and more recently more recently, education. I feel fortunate to join a group where I can engage my passions fully and help make a difference.
See Dr. Bogler’s website for complete BIO
MBCC Survivor Page

Ben Ho Park, M.D., Ph.D.
The Donna S. Hall Chair in Breast Cancer
Professor of Medicine Vanderbilt University Medical CenterHe is currently the Donna S. Hall Chair in Breast Cancer, Professor of Medicine and Associate Director for Basic and Translational Research in the Division of Heme/Onc, Co-Leader of the Breast Cancer Research Program, Associate Director for Translational Research and Director of Precision Oncology at the Vanderbilt-Ingram Cancer Center. His research program involves identifying and validating genetic targets for breast cancer therapy and diagnostics.
See Dr. Ben Ho Park’s website for a complete Bio
John Boyages, MB BS (Hons), PhD, FRANZCR

is a cancer specialist with 30 years of experience in the diagnosis and treatment of breast cancer.  He is the Director and Professor of Breast Oncology at the Macquarie University Cancer Institute.  He was the founding director of the Westmead Breast Cancer Institute, has published more than 135 research and clinical articles and is committed to the dissemination of research findings to lay and professional audiences.
See Professor John Boyages website for complete BIO

Jesse A. Stoff, MD., MDH., FAAFP.

is a highly-credentialed medical expert studying all medical remedies in pursuit of resolving the most challenging health issues of our time. He is recognized for his 35+ years of dedicated work in immunology and advanced clinical research seeking out safer and more effective means of treating cancer and other chronic illnesses. He has spoken worldwide in some of the most sought-after medical conferences on the study of human disease.
See Dr. Stoff’s website for complete Bio

Dr. O’Connor is a graduate of University of Queensland (Medicine).
He completed a three-year post graduate residency at Nambour General Hospital, including six months in the Department of Obstetrics and Gynaecology. He was also the Managing Radiologist at the Women’s Imaging Centre at Kawana Private Hospital before going into private practice.
See Dr. O’CONNOR website for complete Bio

Stephen A. Chagares MD, FACS
is a board certified general, laparoscopic, robotic and breast surgeon with over 20 years of experience providing comprehensive breast care. He is experienced in robotic surgery with training from The European Institute of Oncology (Milan) and is currently the only breast surgeon in the United States who is certified to perform a robotic nipple sparing mastectomy.
See Dr. Chagares’ website for complete BIO
Dr. Matthew Ellis

was recently recruited to Baylor College of M
edicine to serve as the Director of the Lester and Sue Smith Breast Center and to hold the C. Kent Osborne Chair of Breast Oncology. He has been instrumental in developing a Genome Atlas and Therapeutic Road Map for estrogen receptor positive breast cancer and most recently found that metastatic breast tumors harbor mutations and translocations in the estrogen receptor gene that render the tumor resistant to therapies used to block estrogen receptor function. Dr. Ellis has a successful track record in international clinical and translational research, with recent trainees from Brazil, Chile, Poland and Turkey. 
See Dr.Matthew Ellis website for a  Complete Bio